One-week triple therapy with omeprazole, amoxycillin and tinidazole

Triple Therapy with High-Dose Proton-Pump Inhibitor, Amoxicillin triple therapy Triple therapy combining a proton pump inhibitor with two antibiotics, preferably Clarithromycin and Amoxicillin , is the first-choice treatment triple s triple therapy with EFV conferred a higher rate of pVL suppression at 48 weeks than triple thera- py with NFV Quadruple therapy also

triple therapy Triple therapy and methotrexate‐based biologic disease‐modifying antirheumatic drug combinations were superior to methotrexate alone